• Cholesterol Hinders Lipid Nanoparticle Trafficking in Cells

  2026-05-25

  This study reveals that increasing cholesterol content in lipid nanoparticles (LNPs) impedes their intracellular trafficking and reduces nucleic acid delivery efficiency. Using a high-sensitivity tracking platform, the research clarifies the specific roles of LNP components in endosomal escape, offering actionable insights for the design of more effective gene delivery systems.

• JZL184: Optimizing Monoacylglycerol Lipase Inhibitor Workflo

  2026-05-25

  JZL184 stands out as a highly selective monoacylglycerol lipase inhibitor, enabling precise modulation of endocannabinoid signaling in both neuropharmacology and pain models. This guide delivers actionable protocols, troubleshooting strategies, and insights from the latest research, empowering researchers to push the boundaries of CB1-mediated pathway investigations.

• GLI2 Drives Tumor Immune Evasion via WNT and Prostaglandin P

  2026-05-24

  The reference study identifies GLI2 as a central transcriptional regulator enabling tumor immune evasion and resistance to immunotherapy by coordinating WNT ligand and prostaglandin signaling. These findings provide a mechanistic basis for targeting GLI2 to overcome immune checkpoint blockade resistance, offering translational guidance for combinatorial cancer therapies.

• Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model

  2026-05-23

  The reference study reveals that Gramine (1-(1H-indol-3-yl)-N,N-dimethylmethanamine) selectively induces ferroptosis in triple-negative breast cancer (TNBC) cells through a novel CUL3-mediated ubiquitination pathway targeting MTDH. This mechanistic insight highlights Gramine's potential as a precision tool for cancer biology research, specifically for dissecting ferroptosis and ubiquitination processes in aggressive breast cancer subtypes.

• Simvastatin (Zocor): Deep Mechanisms and Research Protocols

  2026-05-22

  Explore Simvastatin (Zocor) as a cholesterol synthesis inhibitor and anti-cancer agent. This in-depth article uncovers advanced mechanisms, protocol insights, and experimental parameters for researchers studying lipid metabolism and oncology.

• Cholesterol Impedes Intracellular Trafficking of Lipid Nanop

  2026-05-22

  This study elucidates how increased cholesterol content in lipid nanoparticles (LNPs) impairs their intracellular trafficking, leading to decreased nucleic acid delivery efficiency. The findings refine mechanistic understanding for optimizing LNP formulations in gene delivery and mRNA therapeutics.

• (S)-(+)-Dimethindene maleate for Selective M2 Receptor Antag

  2026-05-21

  (S)-(+)-Dimethindene maleate addresses the need for high selectivity in M2 muscarinic receptor antagonism, enabling reliable pharmacological modulation in autonomic regulation, cardiovascular, and respiratory physiology studies. It should not be applied where non-selective muscarinic blockade or long-term solution storage is required.

• Modular Inflammation Networks in Genetically Diverse Mouse B

  2026-05-21

  Xiong et al. (2025) present a large-scale, high-throughput RNA-seq approach to map modular inflammation networks in genetically heterogeneous mouse brains. Their work uncovers discrete neuroimmune gene modules and clarifies how specific mutations modulate microglia and astrocyte responses, offering new frameworks for dissecting CNS inflammatory mechanisms.

• Viral-Induced RIPK3 Degradation Modulates Necroptosis and In

  2026-05-20

  Liu et al. uncover how orthopoxviruses, including cowpox virus, deploy a viral protein that hijacks host ubiquitin-proteasome machinery to induce degradation of RIPK3, suppressing necroptosis and shaping virus-induced inflammation. This discovery clarifies a pivotal immune evasion strategy and provides a framework for dissecting proteasome-mediated regulation in antiviral responses.

• Estradiol Benzoate: Mechanistic Precision & Strategic Impact

  2026-05-20

  This thought-leadership article delivers a strategic, evidence-based perspective for translational researchers leveraging Estradiol Benzoate as a potent estrogen receptor alpha agonist. We synthesize mechanistic insight, practical guidance for experimental workflows, and a critical analysis of the competitive landscape, positioning APExBIO's Estradiol Benzoate as an indispensable tool for next-generation hormone receptor signaling research. The discussion bridges recent proteomic advances and high-impact inhibitor screening methodologies, offering a forward-looking outlook while grounding all claims in peer-reviewed and product-verified data.

• Estradiol Benzoate (SKU B1941): Reliable Tool for Estrogen R

  2026-05-19

  This article addresses real laboratory challenges in estrogen receptor signaling assays, focusing on Estradiol Benzoate (SKU B1941) as a reproducible, high-affinity agonist. With scenario-driven Q&A, we explore protocol optimization, data interpretation, and vendor reliability, guiding researchers toward best practices and robust results in ERα-dependent workflows.

• Meropenem in Resistance Surveillance: From Mechanism to Prec

  2026-05-19

  Explore how Meropenem, a β-lactam antibiotic carbapenem, advances resistance surveillance and assay precision amid rising multidrug-resistant pathogens. This article offers a unique, evidence-driven perspective on transmission genetics and practical assay design.

• HyperFluor 488 Goat Anti-Mouse IgG: Detection and Benchmarks

  2026-05-18

  HyperFluor 488 Goat Anti-Mouse IgG (H+L) Antibody is a fluorescently labeled secondary antibody enabling sensitive detection of mouse immunoglobulins. This reagent, developed by APExBIO, offers robust signal amplification and high specificity in immunofluorescence, flow cytometry, and western blot applications.

• Epalrestat: Redefining Neuroprotection via KEAP1/Nrf2 Pathwa

  2026-05-18

  Discover how Epalrestat, a potent aldose reductase inhibitor, is advancing oxidative stress and neurodegeneration research through direct KEAP1/Nrf2 pathway activation. This article provides new technical insights and practical assay guidance, setting it apart from standard reviews.

• Bestatin Hydrochloride: Applied Protocols in Angiogenesis Re

  2026-05-17

  Bestatin hydrochloride (Ubenimex) is a dual aminopeptidase inhibitor enabling precise modulation of angiogenesis and tumor progression pathways. This guide translates foundational research and real-world protocols into actionable, troubleshooting-oriented workflows for advanced cancer and neurobiology studies.

16409 records 1/1094 page Next 12345 下5页 Last page